Finance

Beta
Lists
SVE:WSE
Synthaverse SA
PLN 2.87
+0.70%
(+0.020) 1D
Jul 7, 5:00:01 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for SVE...
Open
PLN 2.82
High
PLN 2.89
Low
PLN 2.82
Mkt. cap
216.66M
Avg. vol.
61.07K
Volume
17.78K
52-wk high
PLN 5.40
52-wk low
PLN 2.60
Shares outstanding
76.02M
No. of employees
214
Open
PLN 2.82
High
PLN 2.89
Low
PLN 2.82
Mkt. cap
216.66M
Avg. vol.
61.07K
Volume
17.78K
52-wk high
PLN 5.40
52-wk low
PLN 2.60
Shares outstanding
76.02M
No. of employees
214
News stories
From sources across the web
Profile
Synthaverse S.A., formerly known as Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company manufactures medicinal preparations. The company's headquarters is in Lublin. Wikipedia
About Synthaverse SA
CEO-
Employees214
Founded1944
Headquarters-
SectorBiotechnology
Websitesynthaverse.com
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.28M
4.79M
17.51M
13.61M
Cost of goods sold
2.11M
3.12M
8.05M
6.43M
Cost of revenue
2.11M
3.12M
8.05M
6.43M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.29M
8.38M
10.86M
10.25M
Operating expense
8.39M
9.07M
17.01M
7.88M
Total operating expenses
10.49M
12.20M
25.06M
14.31M
Operating income
-4.21M
-7.41M
-7.55M
-701.00K
Other non operating income
-
-357.00K
64.00K
-
EBT including unusual items
-6.22M
-8.96M
-8.71M
-4.14M
EBT excluding unusual items
-5.97M
-8.96M
-8.46M
-4.18M
Income tax expense
-1.45M
-1.24M
-1.80M
-537.00K
Effective tax rate
23.37%
13.78%
20.72%
12.96%
Other operating expenses
-900.00K
689.00K
6.15M
-2.37M
Net income
-4.77M
-7.72M
-6.90M
-3.61M
Net profit margin
-75.86%
-161.27%
-39.43%
-26.50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
535.00K
-
Interest expense
-977.00K
-1.20M
-1.49M
-2.58M
Net interest expenses
-977.00K
-1.20M
-956.00K
-2.58M
Depreciation and amortization charges
-
-
-
-
EBITDA
-893.00K
-4.20M
-5.56M
2.67M
Gain or loss from assets sale
250.00K
-
-250.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer